Washington Homeopathic Recalls Natrum Muriaticum 6X Tablets for CGMP Deviations
Washington Homeopathic Products, Inc. is recalling Natrum Muriaticum 6X Tablets because they were not manufactured under current good manufacturing practices.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses or injuries, fitting the criteria for a moderate severity score.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Natrum Muriaticum 6X Tablets, 300-count bottles. The recall was initiated because the products were not manufactured under current good manufacturing practices (CGMP).
The affected product is identified by Lot # BR18B274. A total of 366 bottles were distributed nationwide throughout the United States, Canada, and Saudi Arabia.
Consumers should stop using the product and contact the recalling firm for instructions on how to return it or obtain a refund.
The recalled product
- Product
- Natrum Muriaticum 6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV 25411, barcode 7 40640 64191 0.
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic
- Hazard
- Affected units
- 366
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #: BR18B274
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 16 recalled by Washington Homeopathic Products, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 16 products in this recall →Related recalls
Same manufacturer · Washington Homeopathic Products, Inc.
See all →- LowHomeopathic Kit Recalled for Label Mix-up Between Products
FDA (Drugs) · 2024-07-31
- ModerateHomeopathic Drug Recall: Vaccinotoxinum Products Due to Manufacturing Violations
FDA (Drugs) · 2022-06-22
- ModerateDrug recall: Tuberculinum Bovinum due to manufacturing practice deviations
FDA (Drugs) · 2022-06-22
- ModeratePyrogenium Homeopathic Remedy Recalled for Manufacturing Process Violations
FDA (Drugs) · 2022-06-22
- ModerateHomeopathic Colibacillinum Drug Recall Due to Manufacturing Deviations
FDA (Drugs) · 2022-06-22
Same hazard · cgmp deviation
See all →- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- SevereShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- ModerateShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- HighShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19